Pentatrichomonas hominis antibody and antigen (recombinant protein)

 Download 

Diagnostic anti-Pentatrichomonas hominis antibodies pairs and antigen for animal health (animal Bovines/Cattle infectious disease gastrointestinal infections) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Go to Ruminants disease testing products collection >>

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-VT-P056-Ag01	Recombinant Pentatrichomonas hominis protein	$3090.00
GMP-VT-P056-Ab01	Anti-Pentatrichomonas hominis mouse monoclonal antibody (mAb)	$3090.00
GMP-VT-P056-Ab02	Anti-Pentatrichomonas hominis mouse monoclonal antibody (mAb)	$3090.00

Size： 1mg | 10mg | 100mg

Product Description

Cat No.	GMP-VT-P056-Ag01
Product Name	Recombinant Pentatrichomonas hominis protein
Pathogen	Pentatrichomonas hominis
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Pentatrichomonas hominis antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Pentatrichomonas hominis level test of animal Bovines/Cattle infectious disease with gastrointestinal infections.
Tag	His
Product description	Recombinant Pentatrichomonas hominis proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No.	GMP-VT-P056-Ab01,GMP-VT-P056-Ab02
Pathogen	Pentatrichomonas hominis
Product Name	Anti-Pentatrichomonas hominis mouse monoclonal antibody (mAb)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant Pentatrichomonas hominis antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Pentatrichomonas hominis antibodies in Pentatrichomonas hominis level test of animal Bovines/Cattle infectious disease with gastrointestinal infections.
Product description	Anti-Pentatrichomonas hominis mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Pentatrichomonas hominis antibodies./td>
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Pathogen

Pentatrichomonas hominis is a flagellated protozoan parasite that primarily infects the gastrointestinal tract of humans. It is classified as a eukaryotic organism belonging to the class Trichomonadea. P. hominis is characterized by the presence of five flagella, which it utilizes for motility.

The structure of Pentatrichomonas hominis has not been extensively studied, and its genetic makeup is not well-characterized. However, as a eukaryotic parasite, it possesses typical cellular structures such as a nucleus, mitochondria, and other organelles necessary for its survival and replication.

Pentatrichomonas hominis primarily infects humans, predominantly colonizing the gastrointestinal tract. While it is generally considered commensal, meaning it can coexist with its host without causing harm, there have been suggestions of potential links between P. hominis and certain gastrointestinal disorders. However, further research is required to establish a definitive causal relationship.

The exact mode of transmission of P. hominis is not fully understood. It is believed that the infection can be acquired through ingestion of contaminated food or water, direct contact with infected individuals, or exposure to contaminated environments. P. hominis has been detected in both symptomatic and asymptomatic individuals, further complicating the understanding of its pathogenicity.

The clinical significance of P. hominis infection is not well-defined, as it is often found in conjunction with other infections or conditions. In some cases, P. hominis has been associated with symptoms such as diarrhea, abdominal pain, and bloating. However, the presence of P. hominis alone does not necessarily indicate disease, and its role as a primary pathogen requires further investigation.

Diagnosing Pentatrichomonas hominis infection poses challenges due to its relatively low pathogenicity and limited clinical significance. Currently, there are no standardized diagnostic methods specifically targeting P. hominis. However, nucleic acid-based techniques, such as Polymerase Chain Reaction (PCR), may be employed to detect the presence of P. hominis DNA in clinical samples if necessary. Further research is needed to establish accurate and reliable diagnostic protocols.

Treatment options for P. hominis infection are also not well-documented. In some cases, the infection may resolve on its own without specific treatment. However, if symptoms persist or worsen, healthcare providers may consider antimicrobial therapy targeting other potential pathogens that could be causing the symptoms.

Prevention and control measures for P. hominis infection primarily involve good personal hygiene practices and ensuring the safety of food and water sources. Proper sanitation, handwashing, and appropriate food handling procedures can help reduce the risk of infection.

In conclusion, Pentatrichomonas hominis is a flagellated protozoan parasite that primarily infects the gastrointestinal tract of humans. While it is generally considered commensal, there have been suggestions of its potential involvement in certain gastrointestinal disorders. Diagnosing and understanding the clinical significance of P. hominis infection present challenges, and further research is necessary to establish its pathogenicity, diagnostic methods, and treatment options. Implementing preventive measures can help reduce the risk of infection.

About GDU